Venture Capital

We have extensive experience in venture capital and growth equity transactions, representing both providers and seekers of venture and growth capital.

In serving our clients, we draw on our broad public company and mergers and acquisitions (M&A) experience to implement the growth and eventual exit strategies of our clients. This experience allows us to efficiently represent our venture-backed clients in even the most complex liquidation events, in whatever form they may take—recapitalization, stock or asset sale or initial public offering (IPO). As a full-service firm, we also offer growth and venture-stage companies guidance on a broad range of important legal matters relating to their business activities, including the acquisition and protection of intellectual property, environmental law compliance, commercial loan transactions, labor and employment matters, taxation and dispute resolution.

As a result of the depth and breadth of our experience, and the extensive network we have developed in the venture capital and growth equity community, we also play an active role in introducing entrepreneurs and venture and growth capital firms.

With offices in Nashville and Washington, D.C., our experience in healthcare venture capital transactions is particularly robust. We provide our healthcare venture capital and growth equity clients with a fully-integrated range of services that includes an effective blend of transactional, regulatory and operational counsel. We routinely assist clients with comprehensive due diligence to help them understand key issues and regulatory risks associated with an investment. We also assist our venture capital and growth equity firm clients and emerging growth companies in healthcare investigations and as compliance counsel.

Representative services and experience:

  • Venture and growth equity financings
  • Leveraged dividends and recapitalizations
  • Minority interest transactions
  • “Add on” acquisitions
  • Due diligence and risk analysis
  • Healthcare investigations, regulatory and operational counsel
  • Corporate/general counsel
  • M&A, IPO and “exit transaction” services
  • Representation of Health Enterprise Partners (HEP) – a healthcare and technology focused middle milled-market private equity firm –  and Providence Ventures –  the Venture capital arm of Providence St. Joseph Health (PSJH) and nation’s third largest health system – in its $15 million Series A funding round of Kno2, a healthcare interoperability technology platform.

    We represented Health Enterprise Partners (HEP) – a healthcare and technology focused middle milled-market private equity firm –  and Providence...
    Read More
  • Representation of Providence Ventures, a strategic venture capital firm, in its investment in RxRevu, the leading provider of integrated decision support tools which improve patient access to care. Terms of the transaction were not disclosed.

    We represented Providence Ventures, a strategic venture capital firm, in its investment in RxRevu, the leading provider of integrated decision...
    Read More
  • Representation of Providence Ventures in a $20 million investment in TailorMed Medical, a leading financial navigation software platform. Providence Ventures led the financing round and was joined by new investors UnityPoint Health Ventures, Almeda Ventures, Bridges Israel and Discount Capital with participation from existing investors Accelmed, Sanara Ventures and Triventures.

    We represented Providence Ventures in a $20 million investment in TailorMed Medical, a leading financial navigation software platform. Providence Ventures...
    Read More
  • Representation of Health Enterprise Partners (HEP), a healthcare private equity firm, in its investment in Aware Recovery Care, an in-home addiction treatment provider. Terms of the transaction were not disclosed.

    We represented Health Enterprise Partners (HEP), a healthcare private equity firm, in its investment in Aware Recovery Care, an in-home...
    Read More
    Client Type: Private Company
  • Representation of Oak HC/FT, a venture capital firm investing in early to growth stage tech-enabled companies, as healthcare regulatory counsel in its $75 million Series C investment in Truepill. Truepill currently owns and operates six pharmacies across the U.S. The funds will be used to launch an at-home lab testing network – a new service that will further expand Truepill’s ecosystem of direct-to-patient capabilities, which includes Truepill Health telehealth network, pharmacy fulfillment, a custom-built EMR, and more.

    We served as healthcare regulatory counsel to Oak HC/FT, a venture capital firm investing in early to growth stage tech-enabled...
    Read More
    Client Type: Private Company
  • Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

    We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...
    Read More
    Client Type: Private Company
  • Representation of Health Velocity Capital as lead investor in a $30 million Series C funding round for HealthJoy, a healthcare consumer benefits platform. In addition to Health Velocity Capital, other participating investors included U.S. Venture Partners, Chicago Ventures, and Epic Ventures

    We advised Health Velocity Capital as lead investor in a $30 million Series C funding round for HealthJoy, a healthcare...
    Read More
    Client Type: Private Company
  • Representation of Groups360, a leading online marketplace for meetings, in a combined $50 million investment by global hospitality companies to enhance the GroupSync™ platform and make group travel easier for meeting planners

    We represented Groups360, a leading online marketplace for meetings, in a combined $50 million investment by global hospitability companies to...
    Read More
    Client Type: Private Company
  • Represented Heritage Group in its preferred equity investment in Relode

    We represented the Heritage Group in its preferred equity investment in Relode, an online healthcare recruitment platform. Relode will use...
    Read More
    Client Type: Private Company
  • Represented diagnostic test startup in seed financing round

    We represented IQuity Labs, a life science tech company, in its second round of seed financing totaling nearly $2.4 million....
    Read More
    Client Type: Private Company
Marc E. Ackerman
Counsel
Taylor J. Ashley
Member
Scott W. Bell
Member
Al Bright, Jr.
Member
Bryan  P. Bylica
Member
Laura J. Cohen
Senior Corporate Attorney
Meredith Edwards Collins
Member
Taylor O. Curtis
Associate
J. Page Davidson
Member
Phil Fox
Associate
John L. Fuller
Member
B. Riney Green
Member
Nova D. Harb
Counsel
Brad L. Hart
Member
Lauren Huddleston Henschen
Associate
Michael J. Holley
Member
Angela Humphreys
Member
J. James Jenkins, Jr.
Member
Philip Kassel
Associate
Michael R. Kuffner
Member
Howard H. Lamar III
Member
Philip M. Lewis
Member
Mark Manner
Member
R. Davis Mello
Member
Bryan W. Metcalf
Member
Lori B. Morgan
Member
Jennifer H. Noonan
Member
Janice Parmar
Senior Healthcare Attorney
Tatjana Paterno
Member
Oscar L. Thomas
Counsel
Ryan D. Thomas
Member

Publications

Past Events

Media Mentions & Firm News